Syntrix Biosystems


Drug Candidates

 
 
Syntrix Biosystems is working to discover, develop and commercialize small molecule drug candidates to treat cancer, disorders of inflammation, and stimulate the immune system.
   
Home
Company
Drug Candidates
Research Platforms
Positions
Contact
Compound Pipeline | Clinical Candidates | Clinical Trials

 

 

Compound Pipeline

In addition to our proprietary drug development programs, we partner with academic institutions and pharmaceutical and biotechnology companies to fuel new drug development programs for a range of diseases.  Partners include the University of Washington and the University of Medicine and Dentistry in New Jersey.

Product

Candidate

Clinical

Indication

Research/

Pre-clinical

 Phase 1 Phase 2 Phase 3
Aminopterin Pediatric ALL    

 

  
  Psoriasis        
  Canine Atopic Dermatitis    

 

  
Chemotaxis Inhibitors Rheumatoid Arthritis        
  Bronchopulmonary dysplasia        
Glutathione-S-Transferase Prevention of tumor resistance        
NMDA Inhibitors Antifolate neurotoxicity        

 

 
 
   
 

Syntrix Biosystems, Inc.

215 Clay Street NW, Suite B-5, Auburn, WA  98001

TEL: 253-833-8009 • FAX: 253-833-8127

 

email: info@syntrixbio.com | contact us

© Copyright 2007 Syntrix Biosystems. All Rights Reserved.